|
| Status |
Public on Aug 01, 2013 |
| Title |
T24 Combination_1 |
| Sample type |
RNA |
| |
|
| Source name |
Human bladder carcinoma cell line
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: T24
treatment: AZA and Clorgyline
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment and Quality control experiment performed
|
| Label |
Cy3
|
| Label protocol |
Standard as recommended by Illumina
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Description |
established from a highly malignant grade III human urinary bladder carcinoma
|
| Data processing |
The data was preprocessed by Bioconductor lumi package (version 2.6.0). It was vst transformed and quantile normalized.
|
| |
|
| Submission date |
Oct 17, 2012 |
| Last update date |
Aug 01, 2013 |
| Contact name |
Xiaojing Yang |
| E-mail(s) |
xiaojiny@usc.edu
|
| Phone |
(323)865-0740
|
| Organization name |
USC/Norris Comprehensive Cancer Center
|
| Street address |
1441 Eastlake Ave, Room 7336
|
| City |
Los Angeles |
| State/province |
CA |
| ZIP/Postal code |
90033 |
| Country |
USA |
| |
|
| Platform ID |
GPL10558 |
| Series (2) |
| GSE41676 |
Combinatorial treatment of DNMT inhibitor and LSD1 inhibitor results in cell growth inhibition and reexpression of epigenetically silenced genes (gene expression) |
| GSE41754 |
Combinatorial treatment of DNMT inhibitor and LSD1 inhibitor results in cell growth inhibition and reexpression of epigenetically silenced genes |
|
